Cargando…
Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Monoisoamyl meso-2,3-dimercaptosuccinate (Mi-ADMS) was found to be superior to meso-2,3-dimercaptosuccinic acid (DMSA) in decreasing the body burden of 203Hg in rats under conditions of early treatment. In this experiment Mi-ADMS was used as late treatment for mercury removal. Albino rats aged 6 wee...
Autores principales: | Kostial, K, Kargacin, B, Blanusa, M, Piasek, M, Jones, M M, Singh, P K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567417/ https://www.ncbi.nlm.nih.gov/pubmed/7843123 |
Ejemplares similares
-
Inorganic mercury exposure, mercury-copper interaction, and DMPS treatment in rats.
por: Blanusa, M, et al.
Publicado: (1994) -
A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA)
por: Forman, J, et al.
Publicado: (2000) -
Interaction study of monoisoamyl dimercaptosuccinic acid with bovine serum albumin using biophysical and molecular docking approaches
por: Thakur, Ashima, et al.
Publicado: (2021) -
Quantification and biodegradability assessment of meso-2,3-dimercaptosuccinic acid adsorbed on iron oxide nanoparticles
por: Bemowsky, S., et al.
Publicado: (2019) -
Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults.
por: Asiedu, P, et al.
Publicado: (1995)